Daniel M. Walsh, BA

Clinical and Research Program in Adult ADHD, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

JCP
Solriamfetol for ADHD in Adults
Original Research

October 9, 2023

Some individuals with attention-deficit/hyperactivity disorder (ADHD) may not tolerate or adequately respond to currently available treatments. This study examined the efficacy and tolerability of solriamfetol in the treatment for...
Craig B. H. Surman, Daniel M. Walsh, Nora Horick, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe